Arrhythmia Pharmacology Sudden Cardiac Death 
HeartRhythm
JANUARY 13, 2024
The increased risk of arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation has been a prominent safety pharmacology concern for the last 30 years.
Journal of Cardiovascular Pharmacology
MAY 7, 2024
Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear. Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear.
HeartRhythm
APRIL 30, 2024
Contemporary antiarrhythmic treatment of Timothy syndrome 1 (TS1) is inadequate to prevent sudden cardiac death. Using electroanatomic mapping (EAM) we discovered cardiac activation delay, which creates the milieu for functional reentrant ventricular arrhythmias.
Expert insights. Personalized for you.
71 
Let's personalize your content